Mattei AE, Gutierrez AH, Martin WD, Terry FE, Roberts BJ, Rosenberg AS, De Groot AS
Rudrani Banik, an integrative neuro-ophthalmologist, explains, The GLP-1 hormone acts like a switch, activating a cascade of metabolic processes that regulate hunger, insulin production, and blood sugar control
Who May Be Evaluated for GH-Axis Peptide Therapy Clinicians at HealthRX.com evaluate patients for GH-axis optimisation within evidence-based, FDA-consistent frameworks
One study examined how a gelatin-based breakfast compared to other protein sources for satiety hormone release
In obese patients with T2D without other comorbidities, while both agents promote weight loss, GLP-1RA may be preferred as the first agent, due to greater weight loss at the upper range than SGLT2 inhibitors, particularly with the longer acting liraglutide and semaglutide 78
Less common side effects may include fatigue, vertigo, and hair loss